Methadone Clinics in Minnesota

For those suffering from opiate addiction, methadone treatment centers in Minnesota provide an effective means of treatment that helps to curb cravings and prevent withdrawal for a speedy, more successful recovery.

Methadone Clinics in cities of Minnesota

Medication Treatment for Opioid Use Disorder Across Minnesota

Minnesota treats opioid use disorder (OUD) with the three FDA-approved medications: methadone, buprenorphine, including Suboxone, and naltrexone, including Vivitrol, delivered through both opioid treatment programs (OTPs) and office-based clinics. However, coverage of methadone treatment centers in Minnesota is uneven across the state.

The Twin Cities metro and regional hubs like Duluth, Rochester, and St. Cloud have clinic and office-based options, while many counties in Greater Minnesota have no nearby OTP, so people there often start care by telehealth or through a primary care or emergency department prescriber. The listings on this page connect you to providers near you, and the helpline can talk through options now.

The Three Medications and Where Minnesota Offers Them

Choosing a medication is a decision you make with a clinician and each works differently. Methadone is a full opioid agonist that steadies the brain’s opioid receptors to stop withdrawal and cravings.

Methadone in Minnesota for opioid use disorder is provided only through licensed opioid treatment programs, not regular pharmacies, which is why early treatment usually means daily visits until you earn take-home doses. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, is a partial agonist with a built-in ceiling that lowers overdose risk.

Buprenorphine can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic, and it also comes as a monthly extended-release injection (Sublocade).

Naltrexone, including the monthly Vivitrol injection, is not an opioid at all; it blocks opioid effects, and treatment starts only after a person has stopped using opioids for a set time to avoid sudden withdrawal.

Two settings carry these medications: opioid treatment programs, which dispense methadone and offer the others, and office-based opioid treatment (OBOT), where a clinician prescribes buprenorphine or naltrexone you fill at a pharmacy.

If you are weighing choices, it helps to read how methadone and Suboxone compare, along with the basics of how methadone treatment works and what to expect at an opioid treatment program.

State Rules, Coverage, and Funding in Minnesota

Minnesota’s Medicaid program, called Medical Assistance, covers all three medications for opioid use disorder, and state law bars addiction programs that bill Medical Assistance from turning away patients who take buprenorphine, methadone, or other OUD medications.

MinnesotaCare offers a public option for people who do not qualify for Medical Assistance. Federal rules set the foundation the state builds on. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine for opioid use disorder, which has widened where people can get it.

Federal rules updated in 2024 expanded take-home methadone doses up to a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth, and removed older barriers to getting admitted. Take-home eligibility is decided by the program based on your stability.

As of June 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit. Those telehealth rules run through the end of 2026 and are still being finalized, so confirm current options with a provider.

Methadone in Minnesota remains OTP-dispensed and cannot be picked up at a pharmacy. Minnesota’s Steve’s Law (Minnesota Statutes section 604A.05) allows pharmacists to dispense naloxone without a prescription and gives Good Samaritan protection to people who call 911 during an overdose.

The state’s 2019 Opioid Epidemic Response Law created the Opioid Epidemic Response Advisory Council, which directs settlement and fee funding to treatment and harm reduction. If staying on a steady dose is your concern, here is why a consistent methadone dose matters, and people balancing treatment with a job may want guidance written for employment and privacy questions.

How Overdose Deaths Are Trending in Minnesota

Minnesota’s overdose picture has improved for two years running. The Minnesota Department of Health reported that opioid-involved deaths fell 32% in 2024, with synthetic opioid deaths, mostly illicitly manufactured fentanyl, down 35% from 942 to 610.

The decline reached most of the state. Deaths in Greater Minnesota counties dropped from 419 to 289, and metro counties fell from 919 to 704. Preliminary 2025 figures held roughly even with 2024, still about 28% below the 2022 peak. Officials credit wider naloxone distribution, better access to treatment, and shifts in the drug supply.

Fentanyl still drives most opioid deaths, which is why starting or staying in treatment and carrying naloxone can make a significant difference. You can read more about opioid addiction and how it takes hold if you are trying to understand what you or someone you love is facing.

Starting Treatment and Finding a Program Near You

Getting started usually begins with an intake assessment, in which a clinician reviews your history and, in many cases, can begin medication the same day. Minnesota has built several low-barrier paths to that first dose. MN Bridge supports emergency medical services and emergency departments in starting buprenorphine on the spot, and the state-funded Tackling Overdose with Networks (TOWN) program helps primary care clinics add buprenorphine prescribers.

A network of five emergency departments, including Essentia Health in Duluth and Sanford Health in Bemidji, works to start MOUD and connect patients to ongoing care. If you are coming off fentanyl, timing the first buprenorphine dose matters, because starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans that step with you.

To understand the broader options, see opioid addiction treatment, and if a more intensive start is needed, inpatient treatment is a different track worth knowing about. Use the listings above to find a program in your city, or call the helpline to talk it through.

Pregnancy, Parenting, and Reentry from Incarceration

Two situations in Minnesota carry specific, high-stakes needs. For pregnant patients, methadone or buprenorphine is the recommended standard of care, and Minnesota guidance is explicit that a diagnosis of neonatal opioid withdrawal syndrome (NOWS) does not by itself imply harm or trigger a child-welfare finding.

Treatment improves outcomes for both parent and baby, and you can plan care, including a Plan of Safe Care, with a provider experienced in perinatal care. Our guide on methadone and pregnancy covers this in more depth. For people leaving jail or prison, the weeks after release carry a sharply elevated overdose risk, and Minnesota has invested settlement funds in jail-based MOUD and reentry linkage because continuing medication through that transition saves lives. Families trying to help a loved one through either situation can start with information for families.

Common Questions about Treatment in Minnesota

Does Medical Assistance cover Suboxone and methadone in Minnesota?

Yes, Minnesota’s Medicaid program, Medical Assistance, covers all three FDA-approved medications for opioid use disorder, and programs billing Medical Assistance cannot exclude patients for being on these medications. Coverage details and any prior-authorization steps are worth confirming with the specific clinic and your plan.

Do I have to go in every day for methadone?

Yes, early methadone treatment requires daily dosing and an in-person visit at an opioid treatment program. As you stabilize, federal rules updated in 2024 allow take-home supplies of up to 28 days, with eligibility decided by the program based on your progress.

Can I start buprenorphine by phone in Minnesota?

In many cases, yes. As of June 2026, buprenorphine can be started by telehealth, including audio-only in many situations, without a prior in-person visit. These flexibilities run through the end of 2026 and are being finalized, so confirm what is current with the provider you contact.

How do I get naloxone in Minnesota?

Naloxone, which reverses an opioid overdose, is available over the counter, from pharmacies under Steve’s Law without an individual prescription, and free through community programs such as the Steve Rummler HOPE Network and the state’s MN Naloxone Portal.

Is methadone just trading one drug for another?

No. This is a common myth. Buprenorphine and methadone in Minnesota are prescribed, monitored medications that stabilize brain chemistry so a person can function, work, and stay in recovery; long-term use is legitimate, effective care, not an unfinished step. You can read more in our questions and answers and on how methadone affects the body.

Last Reviewed and Disclosures

Last reviewed June 2026.

Sources:

Minnesota Department of Health, Statewide Trends in Drug Overdose: 2024 Data Update (2024). https://www.health.state.mn.us/communities/overdose/docs/2024prelimdatareport.pdf
Minnesota Department of Health, Medications for Opioid Use Disorder, including MN Bridge, the TOWN program, and the emergency department network. https://www.health.state.mn.us/communities/overdose/treatrecover/moud.html
Minnesota Department of Health, monthly fatal overdose snapshot and 2025 preliminary data (2026). https://www.health.state.mn.us/communities/overdose/data/monthlyod.html
Steve Rummler HOPE Network, Steve’s Law and naloxone access (Minnesota Statutes section 604A.05). https://steverummlerhopenetwork.org/steveslaw/
SAMHSA, Medications for Opioid Use Disorder overview. https://www.samhsa.gov/substance-use/treatment/options
U.S. Drug Enforcement Administration and HHS, Fourth Temporary Extension of telemedicine flexibilities (2026) and Expansion of Buprenorphine Treatment via Telemedicine Encounter final rule (2025). https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care

MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities.

MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com is not owned or operated by any treatment facility and does not endorse any treatment facility or guarantee the quality of care provided or the results to be achieved by any treatment facility. The information provided is not a substitute for professional treatment advice.

Calls to any general helpline may be answered or returned by a paid advertiser. By calling the helpline, you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses, and there is no obligation to enter treatment.